Ophthalmic Formulation Development

Ophthalmic Formulation Development is a specialized pharmaceutical research endeavor that involves the systematic design, optimization, and evaluation of drug delivery systems tailored for topical or intraocular administration in veterinary species, distinguished by its focus on achieving therapeutic efficacy, ocular tissue penetration, and biocompatibility within the unique anatomical and physiological constraints of animal eyes.

353

Publications

13.9K

Citations

1.5K

Authors

485

Institutions

Publications per year

2017–2026

135

Authors

1.5K

  1. MS
    M.F. Saettone

    University of Pisa, Italy

    6 publications · 280 citations

    6

    h-index

  2. ES
    Einar Stefánsson

    University of Iceland, Iceland

    6 publications · 283 citations

    6

    h-index

  3. RH
    Rocío Herrero‐Vanrell

    Universidad Complutense de Madrid, Spain

    5 publications · 145 citations

    5

    h-index

  4. AA
    Asgar Ali

    Jamia Hamdard, India

    5 publications · 323 citations

    5

    h-index

  5. YS
    Yasmin Sultana

    Jamia Hamdard, India

    5 publications · 326 citations

    5

    h-index

1–5 of 1.5K

Venues

  1. International Journal of Pharmaceutics

    33 publications · 1.4K citations

    23

    h-index

  2. Journal of Ocular Pharmacology and Therapeutics

    OPT · 24 publications · 782 citations

    17

    h-index

  3. Drug Delivery

    17 publications · 950 citations

    15

    h-index

  4. Pharmaceutics

    18 publications · 600 citations

    14

    h-index

  5. Drug Development and Industrial Pharmacy

    13 publications · 517 citations

    12

    h-index

1–5